1. Home
  2. BLZE vs TARA Comparison

BLZE vs TARA Comparison

Compare BLZE & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

HOLD

Current Price

$13.50

Market Cap

218.8M

Sector

Technology

ML Signal

HOLD

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$4.09

Market Cap

236.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLZE
TARA
Founded
2007
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.8M
236.1M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BLZE
TARA
Price
$13.50
$4.09
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$7.60
$24.40
AVG Volume (30 Days)
5.2M
771.6K
Earning Date
05-04-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
58.56
38.25
EPS
N/A
N/A
Revenue
$145,835,000.00
$2,948,000.00
Revenue This Year
$10.16
N/A
Revenue Next Year
$10.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.27
N/A
52 Week Low
$3.26
$2.97
52 Week High
$18.25
$7.82

Technical Indicators

Market Signals
Indicator
BLZE
TARA
Relative Strength Index (RSI) 51.66 46.92
Support Level $3.93 $3.69
Resistance Level $18.25 $4.23
Average True Range (ATR) 1.27 0.21
MACD -0.61 0.02
Stochastic Oscillator 16.91 44.14

Price Performance

Historical Comparison
BLZE
TARA

About BLZE Backblaze Inc.

Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: